News for March 2020

News Archive

New AI tool to tackle bad data in Life Science policy-making

A powerful new data research tool has been launched today to better inform policy-makers, strategic investors and companies focused on the UK Life Science industry.

The AMR Centre signs agreement to co-develop treatment for gonorrhoea The AMR Centre signs agreement to co-develop treatment for gonorrhoea

The AMR Centre (AMRC) has today announced a multi-year co-development agreement with Massachusetts-based clinical stage biopharmaceutical company Microbiotix, Inc. to progress a novel treatment to tackle the bacterium that is responsible for gonorrhoea.

Elsevier's International Center for the Study of Research Launches ICSR Lab Elsevier's International Center for the Study of Research Launches ICSR Lab

AMSTERDAM, March 16, 2020 /PRNewswire/ -- The International Center for the Study of Research (ICSR) announced the successful launch of ICSR Lab today. With this new resource, ICSR provides researchers with a powerful cloud-based platform which enables them to analyze large structured metadata datasets. The new service contributes towards ICSR's goal to further the study of research and thus to contribute to the evidence base supporting the practice of research strategy, evaluation and policy.

Drug Discovery Today publishes editorial on new approaches to the discovery of novel agents against 2019-nCoV (COVID - 19) Drug Discovery Today publishes editorial on new approaches to the discovery of novel agents against 2019-nCoV (COVID - 19)

Drug Discovery Today has today published a pre print of an editorial by Yongtao Duan, Hai-Liang Zhu and Chongchen Zhou of Henan Provincial Key Laboratory of Children’s Genetics and Metabolic Diseases, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China

VIB moves forward in the development of a COVID-19 prophylactic

Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique single-domain antibody (VHH) that is capable of binding the SARS-CoV-2 Spike protein of the COVID-19 virus. This antibody was developed in collaboration with two research groups in the US. The team has now established that Fc fusions of the VHH can neutralize pseudotyped SARS-CoV-2, an important step forward in the development of a potential prophylactic drug against the coronavirus. This progress was made possible thanks to the intensive efforts of various teams in the VIB-UGent Center for Medical Biotechnology.

The Current issue of “The view from here” is concerned with Allosterism The Current issue of “The view from here” is concerned with Allosterism

The topic of this month’s newsletter from Drug Discovery Today is “Allosterism”.

Medicines Discovery Catapult Nurture Next Generation Drug Discovery Researchers Medicines Discovery Catapult Nurture Next Generation Drug Discovery Researchers

Medicines Discovery Catapult (MDC) have welcomed a cohort of MRC-funded PhD students as part of a training, talent and skills agenda to help develop the next generation of drug discovery researchers.

Breast screening breakthrough to end unnecessary biopsies Breast screening breakthrough to end unnecessary biopsies

Harnessing photonics, European scientists have created a new mammographic imaging system that determines benign or malignant breast lesions - spelling an end for unnecessary biopsies and anguish for millions of women.